Literature DB >> 24839017

Interdependency between genetic and epigenetic regulatory defects in cancer.

Félix Recillas-Targa1.   

Abstract

Epigenetic regulation is understood as heritable changes in gene expression and genome function that can occur without affecting the DNA sequence. In its in vivo context DNA is coupled to a group of small basic proteins that together with the DNA form the chromatin. The organization and regulation of the chromatin alliance with multiple nuclear functions are inconceivable without genetic information. With the advance on the understanding of the chromatin organization of the eukaryotic genome, it has been clear that not only genetics but also epigenetics influence both normal human biology and diseases. As a consequence, the basic concepts and mechanisms of cancer need to be readdressed and viewed not only locally but also at the whole genome scale or even, in the three-dimensional context of the cell nucleus space. Such a vision has a larger impact than has been previously predicted, since phenomena like aging, senescence, the entail of nutrition, stem cell biology, and cancer are orchestrated by epigenetic and genetic processes. Here I describe the relevance and central role of genetic and epigenetic defects in cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24839017     DOI: 10.1007/978-1-4939-0856-1_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.

Authors:  Erandi Ayala-Ortega; Rodrigo Arzate-Mejía; Rosario Pérez-Molina; Edgar González-Buendía; Karin Meier; Georgina Guerrero; Félix Recillas-Targa
Journal:  BMC Cancer       Date:  2016-03-16       Impact factor: 4.430

2.  Genome-wide 5-hydroxymethylcytosine (5hmC) emerges at early stage of in vitro differentiation of a putative hepatocyte progenitor.

Authors:  Jesús Rafael Rodríguez-Aguilera; Szilvia Ecsedi; Chloe Goldsmith; Marie-Pierre Cros; Mariana Domínguez-López; Nuria Guerrero-Celis; Rebeca Pérez-Cabeza de Vaca; Isabelle Chemin; Félix Recillas-Targa; Victoria Chagoya de Sánchez; Héctor Hernández-Vargas
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.